Effect of ultraviolet germicidal lights installed in office ventilation systems on workers’ health and wellbeing: double-blind multiple crossover trial
Indoor air quality (IAQ) is now a top priority as individuals spend 90% of their time indoors. Traditional HVAC systems focus on temperature, humidity, and basic air quality metrics such as carbon dioxide and VOCs. However, these systems often fail to address airborne pathogens such as viruses, bacteria, and mold spores. Airborne transmission is the primary pathway for many diseases, highlighting a critical gap in building safety. Mitigating this risk requires a multi-faceted approach that includes ventilation, advanced filtration, and germicidal UV light (UVGI). UVGI is a game-changing technology capable of inactivating microorganisms without disrupting airflow or relying on chemicals.
Indoor air quality has become a major concern for modern office environments, where workers often experience unexplained work-related symptoms. A study published exclusively by The Lancet investigated the efficacy of ultraviolet germicidal irradiation (UVGI) systems, specifically Sanuvox UVGI, in reducing microbial contamination within HVAC systems and improving worker health.
Study Overview
The study was a double-blind, multiple crossover trial conducted in three office buildings in Montreal, Canada, involving 771 participants. The UVGI system was alternately turned on and off over a period of 48 weeks to evaluate its impact on microbial contamination and work-related symptoms.
Key Findings
Significant Reduction in Microbial Contamination:
UVGI operation resulted in a 99% reduction in microbial and endotoxin concentrations on irradiated surfaces within the HVAC system.
The study confirmed that bacterial and fungal contamination, known to contribute to respiratory and allergic symptoms, were effectively eliminated.
Improved Worker Health:
Workers reported significantly fewer work-related symptoms when UVGI was active, with an overall reduction in symptoms (adjusted odds ratio of 0.8).
Notable reductions were seen in respiratory symptoms (adjusted odds ratio 0.6) and mucosal symptoms (adjusted odds ratio 0.7), especially among atopic individuals and non-smokers.
Economic and Productivity Benefits:
The study estimated that UVGI installation could potentially reduce work-related symptoms for around 4 million workers in North America.
The long-term cost-effectiveness of UVGI systems is evident when compared to losses from absenteeism due to building-related illnesses.
Safety and Acceptability:
Participants were unaware of whether the system was active or not, ensuring unbiased results.
No adverse effects or complaints were reported, proving the safety of the system.
Conclusion
The installation of Sanuvox UVGI systems in HVAC units offers a proactive solution to microbial contamination, improving indoor air quality and reducing work-related symptoms. The study highlights that UVGI technology can be a cost-effective, safe, and efficient means to promote healthier work environments, benefiting both employees and employers alike.
Implementing UVGI systems could lead to substantial improvements in workplace productivity and a reduction in healthcare costs related to building-related illnesses.
Join us online to hear further details on the study outcomes and its solutions.
The presentation by Jason Vecchio and Sankha Senanayake of Opira Group will delve into the fundamentals of UVGI technology and its installation in Sanuvox UVGI systems. As we face current IAQ challenges and prepare for future health threats, now is the time to invest in safer, healthier indoor environments.
For the full Journal articles, please see below.
Comments